E3 Structure and Content of Clinical Study Reports
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 1, 1996
April 29, 2020
c8d5010c-5951-4f94-9006-a41019269cd8
Related Documents
Q2A Text on Validation of Analytical Procedures
Guidance DocumentMarch 1, 1995Center for Drug Evaluation and Research
S3A Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies
Guidance DocumentMarch 1, 1995Center for Drug Evaluation and Research
E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
Guidance DocumentMarch 1, 1995Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.